Chronic Pain News and Research

RSS

New SBIR award helps Temple scientists to explore the therapeutic potential of novel cannabis analog

More than 20 percent of adults in the United States live with chronic pain. For many affected individuals, long-term physical discomfort negatively impacts overall well-being, leading to reduced work output and increased anxiety and depression.

29 Sep 2021

Psychological treatment provides potent and durable relief for chronic back pain, study finds

Rethinking what causes pain and how great of a threat it is can provide chronic pain patients with lasting relief and alter brain networks associated with pain processing, according to new University of Colorado Boulder-led research.

29 Sep 2021

Nemours receives $10.5 million NIH grant to support research in sickle cell disease

Researchers at Nemours Children's Health, Delaware have received a $10.5 million National Institutes of Health grant to support the Delaware Comprehensive Sickle Cell Research Program.

21 Sep 2021

Study pinpoints a potential pathway for treating epileptic seizures in patients with autism

Autism affects about 2% of children in the United States, and about 30% of these children have seizures. Recent large-scale genetic studies revealed that genetic variants in a sodium channel, called voltage-gated sodium channel Nav1.2, is a leading cause of autism.

15 Sep 2021

Breakthrough discovery could pave the way for new non-opioid painkillers to treat neuropathic pain

Monash University researchers have made a breakthrough discovery that could pave the way for the development of novel non-opioid painkillers to safely and effectively treat neuropathic pain.

8 Sep 2021

Study: Epilepsy brain implant does not induce changes to patients' personalities or self-perceptions

A next-generation brain implant currently in clinical use for treating refractory epilepsy – to help prevent symptoms including seizures – does not induce changes to patients' personalities or self-perceptions, a new study of patient experiences shows.

3 Sep 2021

Leducq Foundation awards $7 million for vascular malformation research

Luisa Iruela-Arispe, PhD, the Stephen Walter Ranson Professor of Cell Biology and chair of Cell and Developmental Biology, is the North American coordinator for an international collaboration that has received a five-year, $7 million Transatlantic Networks of Excellence Program award from the Leducq Foundation.

20 Aug 2021

Research reveals link between widespread pain and heightened risk of dementia, stroke

Widespread pain is linked to a heightened risk of all types of dementia, including Alzheimer's disease, and stroke finds research.

17 Aug 2021

Bioengineers develop implantable piezoelectric therapeutic devices

Bioengineers have developed biocompatible generators that create electrical pulses when compressed by body motions.

16 Aug 2021

Single two-hour session of pain management skills could offer as much benefit as longer-course of CBT

A single two-hour session of a pain management skills class could offer as much benefit as eight sessions of cognitive behavioral therapy (CBT) for patients experiencing chronic low-back pain (CLBP), suggests a study published in JAMA Network Open.

16 Aug 2021

Transcranial focused ultrasound shows promise to treat forms of chronic pain

Neuromodulation comprises a range of therapeutic approaches to relieving symptoms, such as pain or tremors, or to restore movement or function.

16 Aug 2021

Algorithmic clustering by pain distribution may help personalize chronic pain management

Pain distribution as reported on a body map, on its own, can be used to assign patients to distinct subgroups that are associated with differences in pain intensity, pain quality, pain impact and clinically-relevant three-month outcomes, according to a new study published this week in the open-access journal PLOS ONE by Benedict Alter of University of Pittsburgh, US, and colleagues.

4 Aug 2021

Study shows increased risk of overdose and mental health crisis following opioid dose tapering

Opioid therapy is complex. In recent years, a rise in opioid-related deaths and changing prescribing guidelines and regulatory policies have led many physicians to reduce daily doses for patients prescribed stable opioid therapy for chronic pain.

3 Aug 2021

Study: 7 in 10 chronic pain sufferers delayed seeking medical advice during the pandemic

7 in 10 UK chronic pain sufferers delayed seeking medical advice during the COVID-19 pandemic, leaving them feeling increased levels of stress, anxiety and worry, new research from Boston Scientific has revealed.

31 Jul 2021

People with chronic pain may find it harder to regulate emotions

More than three million Australians experience chronic pain: an ongoing and often debilitating condition that can last from months to years.

29 Jul 2021

People's desire to live into older ages reduced by hypothetical adverse life scenarios

A new study sheds light on how the specter of dementia and chronic pain reduce people's desire to live into older ages.

12 Jul 2021

UC San Diego Health completes first surgery to implant novel device for chronic back pain

Advancing options for persons living with chronic back pain, UC San Diego Health has completed the first surgery in the nation to implant a device that uses neurostimulation in the form of electrical pulses to key nerves and muscles responsible for stabilizing the lower back.

8 Jul 2021

Dietary alteration of certain fatty acids can reduce severity of headaches

Migraine is one of the largest causes of disability in the world. Existing treatments are often not enough to offer full relief for patients.

2 Jul 2021

High omega 3 diet associated with reduction of headaches

Eating a diet rich in omega 3 (n-3) fatty acids reduces the frequency of headaches compared with a diet with normal intake of omega 3 and omega 6 (n-6) fatty acids, finds a study published by The BMJ today.

2 Jul 2021

Prenatal THC and CBD exposure impairs offspring's ability to respond to fluoxetine

Scientists at Indiana University have found that significant amounts of the two main components of cannabis, THC and CBD, enter the embryonic brain of mice in utero and impair the mice's ability as adults to respond to fluoxetine, a drug commonly used to treat anxiety and depression and known by the brand name Prozac.

1 Jul 2021

Chronic Pain News and Research

New SBIR award helps Temple scientists to explore the therapeutic potential of novel cannabis analog

Psychological treatment provides potent and durable relief for chronic back pain, study finds

Nemours receives $10.5 million NIH grant to support research in sickle cell disease

Study pinpoints a potential pathway for treating epileptic seizures in patients with autism

Breakthrough discovery could pave the way for new non-opioid painkillers to treat neuropathic pain

Study: Epilepsy brain implant does not induce changes to patients' personalities or self-perceptions

Leducq Foundation awards $7 million for vascular malformation research

Research reveals link between widespread pain and heightened risk of dementia, stroke

Bioengineers develop implantable piezoelectric therapeutic devices

Single two-hour session of pain management skills could offer as much benefit as longer-course of CBT

Transcranial focused ultrasound shows promise to treat forms of chronic pain

Algorithmic clustering by pain distribution may help personalize chronic pain management

Study shows increased risk of overdose and mental health crisis following opioid dose tapering

Study: 7 in 10 chronic pain sufferers delayed seeking medical advice during the pandemic

People with chronic pain may find it harder to regulate emotions

People's desire to live into older ages reduced by hypothetical adverse life scenarios

UC San Diego Health completes first surgery to implant novel device for chronic back pain

Dietary alteration of certain fatty acids can reduce severity of headaches

High omega 3 diet associated with reduction of headaches

Prenatal THC and CBD exposure impairs offspring's ability to respond to fluoxetine

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News